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Abstract The cytochrome P450 enzyme aromatase (P450arom) 
is an important target in breast cancer treatment. We have de- 
signed a 20-base pyrimidine oligodeoxynucleotide (ODN) which 
forms a sequence-specific triple helix (triplex) with a purine-rich 
tract in the P450arom coding sequence. The psoralen-linked 
ODN (Pso20T) formed photo-induced cross-linked products with 
target double-stranded DNA. Cross-linked adducts formed in 
vitro between ODNs and P450arom expression constructs were 
used to transfect COS and human MCF-7 breast cancer cells. 
Levels of aromatase transcripts and enzyme activity were signif- 
icantly lower in cultures transfected with Pso20T-treated cDNA 
relative to controls. Pso20T had a lesser inhibitory effect on 
aromatase xpression from a mutant P450arom construct, con- 
sistent with predicted effects of the mutations on triplex forma- 
tion. These results are compatible with triplex-mediated interrup- 
tion of transcription within intact cells. 
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I. Introduction 
Triple helices (triplexes) form when a third DNA strand 
forms Hoogsteen-type hydrogen bonds with double-helical 
DNA. Recent interest has focused on induction of local triplex 
formation between double-stranded DNA and synthetic oli- 
godeoxynucleotides (ODNs). This antigene approach is seen as 
a means of regulating gene expression, either as an investigative 
tool [1] or for potential therapy [2]. Triplex formation has sev- 
eral potential advantages over the antisense approach: there are 
fewer target molecules per cell and the regeneration rate of 
DNA is far lower than that of RNA. Thus low-dose administra- 
tion could result in durable suppression of gene expression. 
Triplex formation can occur by interaction of a pyrimidine 
third strand with a purine strand in a target duplex. In this 
Pyr. Pur'Pyr motif, thymine binds to an adenine in an AT base 
pair, and protonated cytosine binds to guanine in a GC pair [2]. 
The triplex approach as been used experimentally to modulate 
gene expression. However its use in biological systems i limited 
by sequence r strictions, a requirement for low pH in order for 
cytosine to be protonated, and the fact that the triplex interac- 
tion is of relatively low affinity. Various approaches have been 
used to overcome these problems, including the identification 
of alternative natural triplets [3], and the use of nucleoside 
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analogues [2]. Binding affinity can be increased by covalently 
linking third strand ODNs to intercalating groups such as acr- 
idine [4] or psoralens [5,6]. The latter are photoactive intercalat- 
ing groups which on irradiation at 320-400 nm form stable 
covalent adducts with pyrimidine bases, preferably thymine, at 
one or both ends of the psoralen molecule. Intercalation at a 
TpA step permits photo-induced cross-linking to both DNA 
strands, forming a stable bis-adduct. 
The triplex approach has been used to target purine-rich 
sequences in upstream regulatory regions of genes such as c- 
myc [7,8], the IL2~ receptor [6,9], and progesterone-responsive 
genes [10]. Because the transcribed region of a gene is generally 
much larger than the regulatory sequences, the ability to target 
coding sequences would increase the range of potential targets. 
Thus far this has been reported in a cell-free system [11], and 
in two studies in intact cells, targeting the fl-galactosidase and 
mdrl genes [12,13]. 
The cytochrome P450 enzyme aromatase (P450arom) cataly- 
ses the conversion of androgens tooestrogens and is an impor- 
tant target for the treatment ofhormone-dependent breast can- 
cer [14]. Here we report significant inhibition of P450arom 
expression within live cells, using a psoralen-linked third strand 
ODN which forms cross-linked adducts with a purine-rich re- 
gion in the coding sequence of P450arom. 
2. Materials and methods 
2.1. Oligonucleotides 
Unmodified ODNs were synthesised onan Applied Biosystems au- 
tomated DNA synthesiser using standard phosphoramidite chemistry. 
Psoralen-Cs-phosphoramidite (Cambridge Research Biochemicals) was 
used to prepare ODNs linked at the 5' end to 4'-hydroxymethyl-4,5',8- 
trimethylpsoralen; for experiments in cells these were functionalised at 
the 3' end by a modified amine group using 3' amine-on CPG columns 
(Cruachem Ltd). ODNs were purified by ion exchange HPLC and 
desalted using a Sephadex column. For psoralen-linked ODNs the 
presence of the psoralen was confirmed after purification by fluores- 
cence spectroscopy. Fig. 1 shows the sequences of psoralen-linked third 
strand ODNs and the unmodified 30-mer ODNs used to reconstitute 
the double-stranded target. 
2.2. Electrophoretic mobility shift assays 
The ODN representing the coding strand of the target sequence was 
end-labelled with T4 polynucleotide kinase (New England Biolabs) and 
[y-32p]ATE and purified by electrophoresis through a 20% poly- 
acrylamide gel. It was annealed with a five-fold excess of the comple- 
mentary strand by incubating in 1 x binding buffer (40 mM Tris- 
acetate, 1mM EDTA (TEA), pH 5 or 6, or 40 mM Tris-acetate pH 7 
with 10 mM MgCI2) at 95°C for 5 rain, 37°C for 15 min and room 
temperature for 15 rain. Radiolabelled duplex (10,000 cpm, approxi- 
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mately 10 fmol/reaction) was mixed with 80 fmol-8 nmol third strand 
( IDN (final concentration 4 nM-400 #M) in 1 x binding buffer with 
t mM spermine (Sigma) and 10% sucrose. Reactions were incubated 
ia siliconized Eppendorf vials for 16 h at 15 37°C. The samples were 
~ hilled on ice before irradiation at 365 nm. This was carried out for 10 
- to 30 rain, 4-5 cm from the surface ofa TL-33 transilluminator (UVP 
l~td.). Reaction products were resolved by electrophoresis at room 
~emperature ona denaturing 19% polyacrylamide/7 M urea gel in TBE 
~,uffer (90 mM Tris-borate, 1mM EDTA, pH 8.3) at 200 V for 4 h. The 
els were wrapped in Saranwrap and visualised on a phosphorimager 
,r exposed to autoradiographic film. 
'.3. P450arom expression constructs 
WT P450arom cDNA was cloned from human placental cDNA [16]. 
t was subcloned into expression vectors pCDM8 [17] (Invitrogen Co. 
~an Diego) and pRc/CMV (Invitrogen) to create expression vectors 
~3610 and p3681 respectively [16]. 
?.4. Mutagenesis" tudies 
Wild-type (WT) cDNA was subcloned into pBluescript (Stratagene) 
o prepare single-stranded DNA [15] as a template for mutagenesis. 
Mutant P450arom R265K, which lacks the HgaI site at base 837, was 
~ynthesised with ODN 5'-GCA-GAA-AAA.AGA.CGG-AAG.- 
~TT-TCC-ACA.GAA--G-Y in a mutagenesis reaction using the 
31igonucleotide-directed In Vitro mutagenesis system (Amersham) ac- 
~'ording to the manufacturer's instructions. Mutant progeny were 
~creened by HgaI digestion and DNA sequencing, toconfirm the pres- 
ence of the desired mutation and the absence of other base changes. The 
mutant cDNA insert was subcloned into pCDM8 to create construct 
pR265K for transfection of COS cells. 
2.5. Cell culture and transJection 
COS cells were cultured in Dulbecco's modification of Eagle's me- 
dium (DMEM) with 10% foetal calf serum (FCS), in a humidified 
atmosphere of 10% CO,. Human MCF-7 breast cancer cells were orig- 
inally obtained from the Michigan Cancer Foundation, Detroit, MI. 
They were cultured in RPMI-1640 tissue culture medium with 10% 
FCS. Cultures were negative for mycoplasma infection when stained 
with Hoechst 33258. Triplexes were formed in vitro by mixing 10 #g 
(2.5 pmol) expression vector p3610, pR265K or p3681 with 25 nmol 
ODN in 1 x TEA buffer pH 5. After one hour's incubation at room 
temperature the reactions were irradiated at 365 nm for 5 min on ice. 
Subconfluent cultures of COS and MCF-7 cells were transfected by 
electroporation in HEPES-buffered saline [16]. A fl-galactosidase ex- 
pression vector pCH110 (2 #g; Pharmacia) was cotransfected into COS 
cells for measurement of transfection efficiency. For each experiment, 
ODN-treated constructs were transfected into aliquots of the same cell 
culture within 5 min of one another, to minimise differences in transfec- 
tion efficiency. After electroporation the cells were seeded into fresh 
culture medium with 10% FCS and incubated at 37°C. After 72 h 
parallel cultures were used for northern analysis, aromatase enzyme 
assay and fl-galactosidase assay. In addition, experiments on MCF-7 
cells were repeated over a longer time scale with G-418 selection. Cul- 
tures were transfected with ODN-treated p3681 as described above, and 
after 48 h 600 #g/ml G-418 (Gibco-BRL) was added to select for 
transfected cells. Fourteen days later aromatase assay was pertbrmed 
on neomycin-resistant cells. 
2.6. Enzyme assays 
Aromatase activity was measured in intact cells by the tritiated water 
release method, using as substrate 1 #Ci of 250 nM [lfl-3H]androstene - 
dione (specific activity 24 Ci/mmol, New England Nuclear) as previ- 
ously described [16]. The activity was measured at three time points 
between 30 min and 4 h to confirm linearity of tritiated water elease. 
Cell monolayers were then washed with 50 mM sodium phosphate 
buffer pH 7.4, dissolved in 0.5 M NaOH, and the protein content was 
determined [18]. These results were used to derive the mean ± S.E.M. 
specific aromatase activity expressed as pmol tritiated water released/ 
mg protein/hour. For fl-galactosidase assay, COS cell monolayers were 
washed once in phosphate-buffered saline (PBS) and scraped into 1 ml 
PBS. The cells were pelleted by centrifugation at 12,000 x g for 5 rain 
at 4°C and resuspended in 200 ml fresh fl-galactosidase solution (0.25 
M Tris-C1 pH 7.5, 5 mM dithiothreitol, 15% glycerol). The cells were 
lysed by freeze-thawing and insoluble debris was pelleted at 12,000 x g 
for 5 min. The total protein content of the supernatant was assayed and 
duplicate aliquots of 10 #g were used for a fl-galactosidase assay. The 
results were expressed as OD420 units/mg protein/rain, and for compar- 
ative analysis the aromatase activity was corrected to a fl-galactosidase 
value of 10D unit/mg/min. 
2.7. Statistical ana(y,sis' 
Northern analysis was performed three times, and the images were 
analysed using lmageQuant software (Molecular Dynamics) or by den- 
sitometric scanning of autoradiographs. The results were expressed as 
the mean ±S.E.M. of three blots, expressed asa percent of the intensity 
in the 'no added ODN' control. Analysis of variance and Dunnett's test 
were used to assess the significance of differences in the results of 
Northern blots and enzyme assays. 
3. Results 
The target chosen was at bases 826 845 of the P450arom 
gene coding sequence [19], where there is a 20 bp purine-rich 
sequence interrupted by three CG pairs (Fig. 1). The third 
strand ODN was designed by placing a T tor each AT base pair 
in the target sequence, and a C for every GC pair. At third 
strand positions corresponding to the three CG pairs in the 
target sequence, a thymidine was used, following a report that 
T. CG triplets could be tolerated [3]. 
A 
Wild-type target 
Mutant  target  
5'-CTGATAGCAGAAA/~GACGUAGGATTTCC-3' 
3'-GACTATCGTCTTTTTT~TGC~TCCTAAAGG-5' 
B~eno. B71 831 8~1 850 
5 ' -CTGAT~GCAG~GACGGAAGATTTCC-3 '  
3'-GACTATCGTCTTTTTTCTGCCTTCTAAAGG-5' 
B 
20T 5'- TCTTCTTTTTTCTTCTTCCT-3' 
Pso20T 5'-PsoTCTTCTTTTTTCTTCTTCCT-3' 
PsoControl 5'-PsoCTTTTTCTTTCTTCTTCTTC 3' 
C 
H 
Fig. 1. (a) Target sequences within the P450arom gene coding sequence. 
For band shift assays the 30 bp WT and mutant sequences shown here 
were reconstituted using unmodified 30mer ODNs corresponding to the 
coding and noncoding strands. Within this sequence the 20 bp triplex 
target is underlined. The TpA step at the 5' end of the target sequence 
and the HgaI site are shown in bold, Numbers indicate positions in 
P450arom cDNA. (b) Sequence of third strand ODNs used in this 
study. Pso indicates 4,5',8-trimethylpsoralen. (c) Structure of 4,5',8- 
trimethylpsoralen-linked ODNs. The psoralen derivative 4,5',8-tri- 
methylpsoralen was covalently linked via a pentamethylene li ker to a 
cyanoethyl phosphoramidite. This was used to attach the psoralen to 
the 5'-hydroxyl of Pso20T and PsoControl ODNs (see section 2). 
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Fig. 2. Photo-induced cross-linking ofPso20T to 30bp target. (a) Time 
course of cross-linking. The 32p-labelled duplex (approximately 10 
fmol) was incubated with 800 pmol Pso20T (final concentration 40/IM) 
at pH 5, 15°C, irradiated at 365 nm for 10 s 30 min and electrophoresed 
through a denaturing 20% polyacrylamide g l. Lanes: 1, 32p-labelled 
single strand alone; 2, 32P-labelled duplex; 3 9, 32P-labelled duplex plus 
Pso20T irradiated for: lane 3, 0 s; 4, 10 s; 5, 30 s; 6, 1 rain; 7, 5 rain; 
8, 15 min; 9, 30 rain. To the left are shown the positions of bis-adduct 
(B), monoadduct (M), duplex (D) and single-stranded DNA (S). 
(b) Sequence-specificity of cross-linking assessed using specific or con- 
trol third strands. Radiolabelled duplex (10 fmol) was incubated at 
room temperature (23°C) with 80 fmol-8 nmol Ps20T or PsoControl 
(final concentration 40nM-400,uM) in pH 7 binding buffer with 1 mM 
spermine (lanes 1 7 and 9 15) or without spermine (lane 8). After 
irradiation for 5 min at 365 nm the products were electrophoresed as 
above. Lanes: 1,9, 32p-labelled single strand alone; 2,10, 32p-labelled 
duplex; 3-7, duplex plus Pso20T, at 40 nM (lane 3), 400 nM (lane 4), 
4/IM (lane 5), 40~tM (lane 6), 400/~M (lanes 7,8); 11-15, PsoControl, 
at 40 nM (lane 11), 400 nM (lane 12), 4/.tM (lane 13), 40,uM (lane 14), 
400#M (lane 15). To the left are shown the positions of bis-adduct (B) 
and single strand (S). 
3.1. Evidence for sequence-specific triplex formation in vitro 
For electrophoretic mobility shift assays the target sequence 
was reconstituted using synthetic 30-mer ODNs. Preliminary 
assays were carried out under nondenaturing conditions, and 
confirmed that the unmodified 20T ODN, but not sequence- 
unrelated control 20-mer ODNs, could retard the mobility of 
32p-labelled duplex compatible with triplex formation. This ef- 
fect was demonstrable at pH 5 and 15°C, but not at higher pH 
or temperature (not shown). The radiolabelled duplex was incu- 
bated with Pso20T third strand, irradiated at 365 nm and the 
products were resolved by denaturing gel electrophoresis. Ini- 
tial incubations were performed at pH 5 and 15°C to assess the 
kinetics of photo-induced crosslinking. The results (Fig. 2a) 
showed that bis-adduct formation was detectable after only 10 s 
near-UV irradiation. Cross-linking was virtually complete after 
5 min, when >95% radiolabelled target strand had been con- 
verted to bis-adduct. Two bands of intermediate mobility were 
attributed to dissociating duplex and mono-adduct formed 
after short (10 s-1 rain) periods of irradiation [5]. Cross-linked 
products were also detectable after incubation of Pso20T and 
radiolabelled duplex at room temperature and pH7 (Fig. 2b). 
The effect was dependent on third strand concentration, with 
retarded mobility of the majority of labelled target in the pres- 
ence of 4-400/IM Pso20T. This represented a 104- to 106-fold 
excess of third strand. At pH 5 there was little difference in the 
extent of bis-adduct formation at 4-37°C (not shown). At pH 
7 formation of cross-linked products tended to fall with in- 
creased temperature, although there was no significant differ- 
ence in the amount of bis-adduct formed at 22 and 37°C (not 
shown). To exclude nonspecific rosslinking, a control ODN 
was synthesised with a 5'-trimethylpsoralen group and the same 
number of thymidines and cytosines as Pso20T, but with an 
unrelated sequence (Fig. 1). This PsoControl ODN was incu- 
bated with radiolabelled target duplex, irradiated and subjected 
to denaturing el electrophoresis in parallel with equivalent 
reactions using the specific Pso20T third strand. Under the 
conditions of this assay it was not possible to detect bis-adducts 
in the presence of PsoControl at concentrations upto 400/IM 
(Fig. 2b). 
3.2. EfJbct of triplex formation in vitro on P450arom expression 
in COS cells 
Triplexes were formed in vitro by incubating the P450arom 
expression vector p3610 with third strand ODNs at pH 5, using 
conditions previously shown to convert > 95% duplex to triplex. 
After near-UV irradiation the cross-linked products were used 
to transfect COS cells, and P450arom expression was assessed 
after 72 h. Northern analysis (Fig. 3a,b) showed a reduction in 
the level of P450arom transcripts incells transfected with psor- 
alen-linked ODNs. The reduction was greater in cells trans- 
fected with Pso20T-treated p3610 (11% of the control level 
expressed in the absence of third strand, P < 0.01) than with 
PsoControl (40% control, P < 0.05). Reprobing for actin 
mRNA showed that this effect was not due to loading differ- 
ences. However it could have been due, at least in part, to lower 
transfection efficiency in the presence of the psoralen-linked 
ODNs. Therefore the results of aromatase assay were corrected 
to a fl-galactosidase activity of 10D unit/mg/min, tocompen- 
sate for differences in transfection efficiency. The assay showed 
a time-dependent i crease in tritiated water release in all cul- 
tures (not shown). In the cultures transfected with Pso20T- 
treated cDNA, aromatase activity was suppressed to32% of the 
control evel (P < 0.05; see Fig. 3c). The 20T and PsoControl 
ODNs had no effect on aromatase activity (105% and 112% 
control respectively), confirming that the differences in levels 
of P450arom transcripts on northern blots were due to varia- 
tion in transfection efficiency. 
COS cells were also transfected with the mutant P450arom 
construct R265K, following incubation and cross-linking inthe 
absence and presence of Pso20T (Fig. 4). Both the WT and 
mutant cDNAs showed dose-dependent i hibition of aroma- 
tase enzyme activity in the presence of 1-100 HM Pso20T, with 
an ICs0 of < 1 /IM for the WT and between 1and 10/.tM for 
t yM. Macaulay et al./FEBS Letters 372 (1995) 222 228 225 
t he mutant enzyme. There was no difference in the magnitude 
,,f inhibition at the highest concentration of third strand. How- 
~ver at 1 pM Pso20T the activity of the WT enzyme was inhib- 
ited approximately twofold more than that of the R265K mu- 
tant (35% control compared with 65% for the mutant, 
~' < 0.01), and there was a similar effect at 10pM Pso20T (WT 
ctivity 13% control compared with 28% for the mutant, 
' < 0.01). 
'.3. Effect oJ triplex ]brmation on aromatase xpression in 
MCF-7 cells 
Third strand ODNs were incubated with mammalian 
'450arom expression vector p3681, irradiated and used to 
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transfect human hormone-dependent MCF-7 breast cancer 
cells. Northern analysis was performed on RNA extracted after 
72 h, and the results are shown in Fig. 5a,b. The unmodified 
20T ODN had no effect on P450arom expression (130% con- 
trol), and there was an apparent increase in P450arom tran- 
scripts in the presence of PsoControl (200%, P < 0.01). Cul- 
tures transfected with Pso20T-treated p3681 showed significant 
reduction in the level of full-length aromatase transcripts to 
32% control levels (P < 0.05). This result was quantitatively 
similar to that obtained in COS cells. Northern blotting also 
suggested the presence of shorter transcripts, of approximately 
0.8 kb, in MCF-7 cells transfected with the Pso20T-treated 
construct (Fig. 5a). 
Enzyme assay of duplicate cultures showed aromatase activ- 
ity which was linear with time (not shown), and as expected the 
level of activity with this expression system was much lower 
than in COS cells. The results (Fig. 5c) paralleled the northern 
blots, with a decrease in aromatase activity to 16% control in 
Pso20T-transfected cultures (P < 0.01). There was an apparent 
increase in activity in MCF-7 cells transfected with p3681 pre- 
treated with 20T (180% control, P < 0.01) and PsoControl 
(140%, P < 0.01 ). To assess how far these results were attributa- 
ble to differences in transfection efficiency, the experiments 
were repeated over a longer time-scale, using G418 to select for 
transfected cells. After 14 days G418-resistant colonies were 
analysed for aromatase activity. The release of tritiated water 
was linear with time in all cultures, and the specific activity was 
5- to 10-fold higher than in cells which had not been subjected 
to selection (Fig. 6). The previously noted increase in aromatase 
activity in the 20T- and PsoControl-treated cultures was not 
seen here, suggesting that it may have been attributable to 
differences in transfection efficiency. However the relative re- 
duction in aromatase activity in cells transfected with Pso20T- 
treated cDNA was very similar (2.0 pmol/mg/h, 14% control, 
P < 0.01) to that observed previously. This result was signifi- 
cantly lower than the activity measured in cultures transfected 
with 20T (2.0 vs. 10.5 pmol/mg/h, P < 0.01) and PsoControl 
(2.0 vs 14.9 pmol/mg/b, P < 0.01). 
4-- 
Fig. 3. Effect of triplex formation on P450arom expression by COS 
cells. Triplexes were formed between third strand ODNs and COS cell 
expression vector p3610 as described in section 2. The samples were 
irradiated at 365 nm and used to transfect COS cells. After 72 h. total 
RNA was prepared by the method of Chomczynski and Sacchi [25], and 
5 10pg was electrophoresed through a 1% agarose-formaldehyde gel, 
transferred to Hybond-N + (Amersham) and probed with a riP-labelled 
1.5 kb insert made by digestion ofp3681 with HindlIl and NotI. Filters 
were stripped and reprobed for actin to correct for loading differences. 
Parallel cultures were assayed for aromatase and fl-galactosidase activ- 
ity. (a) Northern blot showing expression of P450arom transcripts after 
transfection with WT expression construct (p3610) irradiated in the 
absence of ODN or with 100 pM 20T, Pso20T or PsControl ODN. The 
filter was stripped and reprobed for actin to correct for loading differ- 
ences. (b) Quantitative analysis of P450arom expression by COS cells. 
Bar chart shows the mean + SEM of results from 3 separate xperi- 
ments, corrected for the level of actin transcripts and expressed as % 
expression in the 'No ODN' control. (c) Aromatase nzyme activity 
expressed by transfected COS cells. The measured levels of aromatase 
activity were corrected to a fl-galactosidase activity of 1 OD unit/mg/ 
min to control for differences in transfection efficiency. Points represent 
the mean +S.E.M. of the results of 3 separate xperiments. 
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Fig. 4. Effect of Pso20T on aromatase activity expressed by COS cells 
transfected with WT or mutant P450arom cDNA. Triplexes were 
formed between Pso20T and COS cell expression vectors p3610 or 
pR265K. After cross-linking an J addition of pCH110 the samples were 
used to transfect COS cells. The cultures were incubated for 72 h and 
were assayed for aromatase and fl-galactosidase activity. Points repre- 
sent the mean + S.E.M. of 3 values, corrected for transfection effi- 
ciency. 
4. Discussion 
We have aimed to evaluate the potential of triplex formation 
to inhibit transcription elongation, and therefore chose a target 
within a coding exon of the P450arom gene. The selected 20bp 
sequence present within exon VII [19] included three CG pairs, 
and so did not represent a perfect riplex target. Using a mod- 
ification of the established rules [3], it was possible to design a 
third strand ODN which demonstrated effects in electro- 
phoretic mobility shift assays compatible with triplex forma- 
tion. The use of psoralen-ODN conjugates has been shown to 
permit photo-induced cross-linking of the two target strands of 
DNA [5,6,20,21]. We adopted this strategy because the 
P450arom target sequence possesses a TpA step at the triplex- 
duplex j unction, suggesting the potential for cross-linked bisad- 
duct formation. We used 4,5',8-trimethylpsoralen b cause this 
modification increases the dark binding affinity and quantum 
yield of photo-addition and is much more reactive than unsub- 
stituted psoralen [22]. As predicted, the double-stranded target 
sequence formed sequence-specific bisadducts when cross- 
linked with the trimethylpsoralen-ODN conjugate, Pso20T. 
This effect was seen following incubations at physiological pH 
and temperature despite the absence of other modifications 
reported to reduce the requirement for low pH [11,23]. 
Having obtained results in cell-free systems compatible with 
triplex formation under physiological conditions, we evaluated 
the effect of triplexes formed in vitro on P450arom expression 
by intact cells. For this purpose we used psoralen-linked ODNs 
Y-modified with an amine group. This modification has been 
shown to confer resistance to serum nucleases without imped- 
ing triplex formation ([9]; Macaulay et al., unpublished obser- 
vations). In COS cells there was clear evidence of reduction in 
the level of P450arom transcripts in cells transfected with the 
WT expression vector previously cross-linked to Pso20T. In 
parallel with this we observed a reduction in aromatase activity 
as measured by the tritiated water release assay. These inhib- 
itory effects on levels of P450arom transcripts and aromatase 
enzyme activity were not seen in the presence of the unmodified 
20T or PsoControl ODNs. 
As a further check on the specificity of the interaction with 
P450arom cDNA, we performed transfections using Pso20T 
cross-linked to WT or mutant expression constructs. Two 
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Fig. 5. Effect of triplex formation on P450arom expression by trans- 
fected MCF-7 breast cancer cells. (a) Northern blot showing expression 
of P450arom transcripts. (b) Quantitative analysis of P450arom expres- 
sion by MCF-7 cells. (c) Aromatase enzyme activity expressed by trans- 
fected MCF-7 cells. Details as for legend to figure 3, except that 
pCH110 cotransfection was not used to correct he values hown in (c) 
for transfection efficiency. 
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Fig. 6. Effect of triplex formation on expression of aromatase activity 
14 days after G418 selection of transfected MCF-7 cells. (a) Tritiated 
water elease increased with time in all cultures, and was suppressed in
cultures transfected with P450arom expression vector cross-linked to 
100 pM Pso20T. (b) Mean specific aromatase activity expressed by 
neomycin-resistant MCF-7 cells. There was no significant difference 
between results obtained for cultures transfected with P450arom ex- 
pression vector irradiated in the absence of third strand ODN or with 
unmodified 20T or PsoControl. The aromatase activity detected in 
cultures transfected with expression vector crossdinked to 100 /~M 
Pso20T was significantly lower (P < 0.01) than all other values. 
changes were introduced into the WT sequence; a silent G to 
A mutation at base 843 which obliterated the HgaI site, and a 
C to G mutation at base 841. The effect of the latter is substi- 
tution of lysine for arginine at residue 265 of aromatase. Com- 
puter modelling suggests that this is a surface residue distant 
from the active site of human P450arom ([26]; C.A. Laughton, 
personal communication). The consequence for triplex forma- 
tion is the replacement of stable triplets T. CG and C" CG by 
T. CG and C" AT, respectively. The latter is potentially desta- 
bilising according to previous reports [3,27]. COS cells trans- 
fected with pR265K expressed etectable aromatase activity 
which, like the WT activity, showed dose-dependent i hibition 
after cross-linking with Pso20T. The ICs0 for the effect on the 
WT construct was, at <1 /tM, approximately 10-fold lower 
than that for the R265K mutant. The individual values at 1 and 
10/~M Pso20T suggested that the inhibition of WT activity was 
approximately twice as potent as the effect on the mutant activ- 
ity. Thus the effect of the specific psoralen-linked ODN on 
aromatase activity was sensitive to individual base changes. The 
differential effect of Pso20T on suppression of aromatase activ- 
ity expressed by WT and mutant aromatase activity was consis- 
tent with the predicted change in triplex binding affinity on the 
introduction of destabilising mutations [3,27]. 
We note that the specific 20T and Pso20T third strand se- 
quences could form an imperfect heteroduplex, including a 
perfectly matched contiguous sequence of 10 bp, with 
P450arom mRNA transcribed from the target region of the 
P450arom gene: 
V V 
WT mRNA 5 ' -CTGATAGCAGAAAAAAGACGCAGGATTTCC-  3 ' 
Pso20T 3 ' - T C C T T C T T C T T T T T T C T T C T - P s o - 5  ' 
Thus it is possible that Pso20T-mediated inhibition of aroma- 
tase expression could be attributable to an antisense ffect, 
similar to that reported by Praseuth and colleagues [28]. How- 
ever of the bases mutated in pR265K (arrowed above), one 
involved an existing mismatch (underlined), and the other was 
outside the region of potential antisense interaction. Therefore 
these changes hould have made no difference to an antisense 
effect. The observed ifferential effect of Pso20T on the WT 
and mutant cDNA targets is not consistent with this, but is 
consistent with the predicted effect on triplex formation 
The COS cell expression system is based on run-away repli- 
cation of the transfected plasmid [24], and it was possible that 
inhibition of DNA replication could cause the observed reduc- 
tion in P450arom expression. Therefore these xperiments were 
repeated in a non-replicative transfection system. WT MCF-7 
cells express very low levels of aromatase activity detected only 
on prolonged (24 h) enzyme assay, and endogenous P450arom 
transcripts are not detectable by Northern blotting [16]. Trans- 
fected MCF-7 cultures expressed measurable P450arom tran- 
scripts and aromatase nzyme activity after 72 h. There was 
significant reduction in the level of full-length P450arom tran- 
scripts and enzyme activity in cultures transfected with 
P450arom cDNA cross-linked to Pso20T. The degree of inhibi- 
tion was similar to that observed in COS cells. In addition, 
northern analysis uggested the presence of shorter transcripts 
which could indicate truncation of transcription, or degrada- 
tion of full-length mRNA. 
To exclude variation in transfection efficiency as a cause for 
differences in levels of full-length transcripts and enzyme activ- 
ity, the experiments were repeated following G-418 selection for 
transfected cells. Assays performed after 14 days revealed sig- 
nificant reduction in aromatase activity, similar to that ob- 
served after 72 h. This confirmed that the fall in aromatase 
activity was not simply a transfection artefact, and that the 
effect on gene expression was durable. The continued expres- 
sion of neomycin resistance from the same construct is consis- 
tent with a sequence-specific effect on P450arom transcription. 
The demonstration f reduction in enzyme activity after a rela- 
tively long time period argues against a significant antisense 
228 I4M. Macaulay et al./FEBS Letters 372 (1995) 222~28 
effect: free ODN would be subject to degradation by cell and 
serum nucleases, and would be progressively diluted in dividing 
cells. The apparent durability of the effect we observed here is 
in contrast o studies in transfected HeLa cells, where triplex- 
mediated inhibition of reporter gene expression was reversed 
after 48-72 h due to repair of psoralen adducts [12]. It is possi- 
ble that the inhibition we observed in MCF-7 cells after 14 days 
represented the residual effect of a greater degree of inhibition 
at earlier time points, or that MCF-7 cells have different repair 
mechanisms from HeLa cells. 
In conclusion, these results are compatible with triplex-medi- 
ated stalling of RNA polymerase, suggesting that purine-rich 
tracts within coding sequences may be targeted by triplex form- 
ing oligonucleotides. The ability to demonstrate this in intact 
cells suggests the potential for use of the triplex approach to 
modulate gene expression in vivo. 
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